Cargando…

Should Cell Culture Platforms Move towards EV Therapy Requirements?

Detalles Bibliográficos
Autor principal: Aiastui, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309209/
https://www.ncbi.nlm.nih.gov/pubmed/25674086
http://dx.doi.org/10.3389/fimmu.2015.00008
_version_ 1782354655598084096
author Aiastui, Ana
author_facet Aiastui, Ana
author_sort Aiastui, Ana
collection PubMed
description
format Online
Article
Text
id pubmed-4309209
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-43092092015-02-11 Should Cell Culture Platforms Move towards EV Therapy Requirements? Aiastui, Ana Front Immunol Immunology Frontiers Media S.A. 2015-01-28 /pmc/articles/PMC4309209/ /pubmed/25674086 http://dx.doi.org/10.3389/fimmu.2015.00008 Text en Copyright © 2015 Aiastui. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Aiastui, Ana
Should Cell Culture Platforms Move towards EV Therapy Requirements?
title Should Cell Culture Platforms Move towards EV Therapy Requirements?
title_full Should Cell Culture Platforms Move towards EV Therapy Requirements?
title_fullStr Should Cell Culture Platforms Move towards EV Therapy Requirements?
title_full_unstemmed Should Cell Culture Platforms Move towards EV Therapy Requirements?
title_short Should Cell Culture Platforms Move towards EV Therapy Requirements?
title_sort should cell culture platforms move towards ev therapy requirements?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309209/
https://www.ncbi.nlm.nih.gov/pubmed/25674086
http://dx.doi.org/10.3389/fimmu.2015.00008
work_keys_str_mv AT aiastuiana shouldcellcultureplatformsmovetowardsevtherapyrequirements